Healthcare Whitepaper and Newsletter

Our multidimensional, purposeful, and credible market analysis will help accelerate your business growth and overcome challenges with a practical approach.
Complex Regional Pain Syndrome Newsletter
In Focus
Complex Regional Pain Syndrome
A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believed to be caused by injury, or malfunction of, the peripheral and central nervous systems. DelveInsight, through its newsletter series, aims for increased awareness about the indication, its underlying causes, etiology, symptoms, and risk factors among its readers. The newsletter is a brief introduction of the indication - Complex Regional Pain Syndrome, with its epidemiological analysis, preponderance, treatment approaches, unmet needs in the market, and upcoming therapies in the horizon.
Over the last months, the world has faced one of the most unexpected challenges in the form of a novel coronavirus, SARS-CoV-2, infection. Through the whitepaper, DelveInsight aims to make its clients and users aware of the exact scenario of the novel coronavirus SARS-CoV-2 and the disease COVID-19. The whitepaper is a detailed description of SARS-CoV-2 virus, its morphology and pathophysiology, and the trends of the patients affected, most prevalent symptoms, as well as understand the asymptomatic traits.
Myasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skeletal muscles, including the muscles of arms and legs, leading to breathing difficulty and mobility issues. When the muscles affected are from multiple muscle groups throughout the body, it is called generalized myasthenia gravis (gMG).With a higher diagnosed prevalence of generalized Myasthenia Gravis in the United States of approximately 32,188 cases, gMG has an equal prevalent ratio in males and females.
The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in areas like the spleen, liver, and bone marrow. With an equal prevalence in males and females, the overall frequency of Gaucher Disease is approximately 1 in 50,000 to 1 in 100,000 live births. The newsletter by DelveInsight offers a crisp overview of the indication, its subtypes and symptoms.
A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As per DelveInsight, the total prevalent population of Duchenne Muscular Dystrophy in the 7MM was found to be 31,386, whereas, total diagnosed prevalent population was found to be 26,678 in 2017. The newsletter will help the readers and clients to gain a perspective on the latest trends in the Duchenne Muscular Dystrophy Market, its epidemiology and the role of mutations that form the underlying cause of the disease.
An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythematosus, belongs to the family of Lupus Erythematosus (LE). Through the newsletter, DelveInsight brings to light about a condition that had a prevalence of 327,569 in the US alone in 2017. The newsletter provides an overview of the indication, symptoms, causes, and etiology. It also put forward the historical epidemiological trends listing its prevalence and incidence, with the 11-year forecast.
A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believed to be caused by injury, or malfunction of, the peripheral and central nervous systems. DelveInsight, through its newsletter series, aims for increased awareness about the indication, its underlying causes, etiology, symptoms, and risk factors among its readers. The newsletter is a brief introduction of the indication - Complex Regional Pain Syndrome, with its epidemiological analysis, preponderance, treatment approaches, unmet needs in the market, and upcoming therapies in the horizon.
Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people, and is a result of mutation associated with the gene FMR1. DelveInsight's newsletter series brings to light an overview of Fragile X syndrome, underlying causes, risk factors, etiology, and symptoms. The newsletter provides a brief scenario of the prevalence and incidence of the disease, present treatment approaches and the therapies and drugs in the pipeline for the disease.
An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also called Glycogen Storage disease type II, Pompe disease affects around 5,000 to 10,000 people worldwide, with an equal preponderance in Males and females.
BREXIT, the 'EXIT' of 'BRITAIN' from 'EUROPEAN UNION', shook the whole world when the United Kingdom voted in the favor of leaving the EU. This was mainly done to access greater control of the country's borders as well as economy, which also led to major impact on various countries that have conducted business and trade within the UK borders. After the vote, the country has been wrought in uncertainty related to political, regulatory and economic scenario.
Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the quality of lives of patients. There is still a lack of understanding in the abundance of the rare diseases prevalent globally and treatment approaches that are being adapted. DelveInsight, with its new newsletter series, aims to put forward enriching content related to various rare diseases for a crystal-clear picture of the rare disease, their therapies, and market trends.
Cancer has gripped the human society in its clutches in such a way that there has been many advancements to treat the same, but with little success. The full extent of the disease can only be measured by the population that it has plagued, and how varied it has become over the course of years. Cancer by Numbers provide us with the degree of devastation it has incurred among various populations, and provides us with a better idea on the level of progress needed to eradicate this morbid indication. It also sheds light on the blockbuster drugs along with potential therapies for the cancer.
US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country. The newsletter Cancer in the US substantiates the increasing incidence and prevalence of major cancer sub-types in the American patient population, drawing conclusions related to the seriousness of the matter. This edition further points out to the top selling cancer drugs in the country and how new and innovative therapies are being researched to limit the devastating impact of this debilitating disease. Read on to know more